LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2016

May 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2016-05-16

Reporting Person: TYLE PRAVEEN (EVP, R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-16	Stock Option (Right to Buy)	$12.24	A	100000	Acquired	2026-05-16	Common Stock (100000)	Direct

Footnotes

F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (5/16/2017) and vests 1/48th per month for each month of service thereafter.